Fingerprint
Dive into the research topics of 'Clinical evaluation of moroctocog alfa (AF-CC), a new generation of B-domain deleted recombinant factor VIII (BDDrFVIII) for treatment of haemophilia A: Demonstration of safety, efficacy, and pharmacokinetic equivalence to full-length recombinant factor VIII'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically